Adage Capital Partners’s Alto Neuroscience ANRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$43.4M Buy
1,701,913
+101,913
+6% +$3.06M 0.06% 292
2026
Q2
$42.2M Buy
1,600,000
+1,215,000
+316% +$28.1M 0.06% 321
2026
Q1
$8.65M Buy
+385,000
New +$7.14M 0.01% 717

Other funds holding ANRO

Adage Capital Partners's ANRO Position: Q3 2026 in Review

Adage Capital Partners increased its Alto Neuroscience (ANRO) stake by 6.4% in Q3 2026, buying an estimated $3.06M and bringing the position to 1,701,913 shares worth $43.4M. The position accounts for 0.06% of the portfolio, ranked #292.

Adage Capital Partners first reported a position in ANRO in Q1 2026 and has held it in 3 quarters since. 133 funds tracked by Wall St. Rank hold ANRO as of Q3 2026.

  • Adage Capital Partners held 1,701,913 shares of Alto Neuroscience worth $43.4M as of Q3 2026.
  • Adage Capital Partners bought 101,913 Alto Neuroscience shares in Q3 2026, an estimated $3.06M.
  • Alto Neuroscience made up 0.06% of Adage Capital Partners's portfolio in Q3 2026, its #292 holding.
  • Adage Capital Partners first reported a position in Alto Neuroscience in Q1 2026 and has held it in 3 quarters since.
  • 133 funds tracked by Wall St. Rank held Alto Neuroscience as of Q3 2026.

Based on Adage Capital Partners's 13F filing for Q3 2026, filed 16 Nov 2026.